Catalyst Wire Dossier Catalyst Wire Dossier

Anti-PB230

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-PB230, covering 2016-08-30 to 2016-08-30. Get the full timeline:

Most recent: Clinical Trial Update: Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous Pemphigoid

See pricing